Brind.

Veeva Systems is strategically pivoting its operations, targeting the life sciences CRM market while transitioning from Salesforce's cloud infrastructure to its proprietary Vault platform.

4 reports, 1 independent Updated Jul 24
Gone quiet
Reports
4
Developments
2
Repetition
75%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Veeva Systems is strategically pivoting its operations, targeting the life sciences CRM market while transitioning from Salesforce's cloud infrastructure to its proprietary Vault platform.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Veeva Systems, Eli Lilly and Company, and Salesforce renewed a global partnership focused on AI adoption and migrating from legacy infrastructure.Sub-event
  2. Veeva is shifting its focus to the life sciences CRM market and moving to its proprietary Vault platform away from Salesforce's infrastructure.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • ZacksVeeva vs. Salesforce: Which Life Sciences CRM Stock Is the Better Buy? A significant shift is underway in the enterprise software landscape, particularly within the life sciences customer relationshi
  • ZacksVeeva's Vault Vision: Can It Thrive After Parting With Salesforce? Veeva Systems VEEV is entering a pivotal phase as it gradually transitions away from Salesforce’s infrastructure, aiming to complete
  • ZacksVeeva Systems' Vault CRM Momentum Builds With Top Biopharma Adoptions Veeva Systems VEEV is seeing strong momentum in its next-gen Vault CRM (customer relationship management) offering, with fiscal f
  • Unknown outlet